The 2020 Story

World ADC is pleased to announce the winners at the 7th Annual World ADC Awards at World ADC Digital, 2020

The 7th annual World ADC Awards showcased the innovation, leadership and devotion shown by the best companies, teams and individuals in the industry.

Across 9 categories the Awards recognized the extraordinary endeavors, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today.

The 7th Annual World ADC Awards Ceremony took place at 3pm, Wednesday September 17 at the global virtual World ADC digital meeting.

The finalists and winners were shortlisted from over 1000 votes cast and scientific proposals from each submission were evaluated by our Judging panel.

Please note there was an error in the ADC Awards video, the shortlist for Best ADC platform technology is as follows:

Ajinomoto

IntoCell

LegoChemBio

Mersana

Sutro

Synaffix

Elayda Hearne, Program Director, World ADC San Diego stated:

“The Finalists for 2020 reflects the exciting year we have seen for the ADC space with novel innovations and world class research truly accelerating the field. We are delighted to celebrate and highlight a spotlight on companies that demonstrate the dedication, leadership and innovation that exists in this crucial area of oncology therapeutics.”

Jagath Reddy Junutula,Senior Vice President of Research and Development, ModMab Therapeutics stated:

The World ADC Summit is my favorite scientific conference as it unifies all ADC players on to a single platform. In addition, World ADC Awards brings to light the excellence within the ADC field. The World ADC Awards recognizes the innovation, leadership, and devotion on a global platform. I am truly honored to be part of the judging for World ADC Awards and I am delighted to see the growth in the ADC field and the continuing momentum and progress in the ADC field”

The 2020 Winners Are:

Best ADC Platform Technology
Synaffix – Winner

Legochem Bio – Runner Up


Best New Drug Developer
Sutro Biopharma – Winner
Mersana Therapeutics – Runner Up

 

Most Promising Clinical Candidate
DS-1062 (Daiichi Sankyo) – Winner
Loncastuximab Tesirine (ADC Therapeutics) – Runner Up

 

Best Contract Manufacturing (CMO) Provider

Piramal – Winner
BSP Pharmaceuticals – Runner Up

 

Best Contract Research (CRO) Provider
Abzena – Winner

NJ Biopharmaceuticals  – Runner Up

 

Best Pre-Clinical Publication

Winner:

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Hoggatt J, Saez B, Pang WW, Mansour MK, Tate TA, Chan YY, Walck E, Wernig G, Shizuru JA, Winau F, Scadden DT, Rossi DJ.Nat Commun. 2019 Feb 6;10(1):617. doi: 10.1038/s41467-018-08201-x.


Winner:

AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.

Yamada K, Shikida N, Shimbo K, Ito Y, Khedri Z, Matsuda Y, Mendelsohn BA.Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5592-5597. doi: 10.1002/anie.201814215. Epub 2019 Mar 29.

 

Best Clinical Publication

Winner:


Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators.N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017.

 


Individual Input to the Field 2019
Also Braca (BSP Pharmaceuticals)

 

Long Standing Contribution to the Field
Rakesh Dixit

 

For more information about the World ADC Digital conference visit: www.worldadc-digital.com

For more information about the World ADC Digital conference visit: www.worldadc-digital.com